Abstract Objective: To evaluate the cost-effectiveness of liposomal Irinotecan (Onivyde) in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) compared to gemcitabine plus nab-paclitaxel (GemNabPac), for the first-line treatment (FLT) of adult...
Publications
Persistent disease burden despite advanced therapies in inflammatory bowel disease: a real-world patient-reported survey from Greece
Abstract Objectives: Despite therapeutic advances, inflammatory bowel disease (IBD) remains a lifelong debilitating disorder with substantial burden. The study aimed to investigate disease burden and unmet needs in IBD patients receiving advanced therapies in Greece....
Editorial: Advancing Health Technology Assessment and patient-reported outcomes: innovations and implications for health economics and outcomes research
Health Technology Assessment (HTA) has become a central instrument for evidence-informed healthcare decision-making, supporting reimbursement, pricing, prioritization, and resource allocation across health systems facing increasing clinical, economic, and societal...
Disease burden and unmet medical need in severe hemophilia in Greece: insights from clinicians and patients
Abstract Objectives: Hemophilia is the most common severe hereditary bleeding disorder, with significant unmet needs in its management. This study aimed to assess the burden and unmet needs of severe hemophilia in Greece from a clinician and patient perspective....
Artificial Intelligence in Health Economics: Opportunities and Challenges for the Future: A Targeted Literature Review
Abstract:OBJECTIVES: To evaluate the economic implications of artificial intelligence (AI) integration in healthcare, with a focus cost-efficiency, resource optimization, healthcare equity, and impact on insurance and reimbursement frameworks. This targeted literature...